Chest
Thoracic Urgery: Clinical InvestigationsAmiodarone and the Development of ARDS After Lung Surgery
Section snippets
METHODS
A prospective open randomized study was planned for 100 consecutive pneumonectomy and 200 consecutive lobectomy cases, comparing amiodarone, verapamil, or placebo as prophylactic treatment for atrial fibrillation.
All patients in whom a pulmonary resection was performed were considered for the study, within 1 h of return from surgery to the ICU. Exclusion criteria consisted of a heart rate of less than 50 beats per minute, systolic blood pressure below 100 mm Hg, atrial dysrhythmias, heart
RESULTS
The prospective study was interrupted on July 29, 1992, because of severe life threatening side effects in three postpneumonectomy patients in the amiodarone treatment group. At that time, 64 patients had been included after lobectomy and 32 patients after pneumonectomy.
The results are summarized in Table 1. Systemic hypotension occurred shortly after the start of the infusion of verapamil in nine patients and subsided rapidly after the cessation of verapamil therapy and fluid replacement.
Adult
DISCUSSION
Pulmonary toxicity is the most serious noncardiac side effect attributed to amiodarone therapy. The overall incidence of amiodarone pulmonary toxicity has been estimated at 5 to 10 percent of treated patients.8
Amiodarone-induced pulmonary disease usually appears as a subacute or chronic disease, although in some cases there may be rapid progression toward respiratory failure.9
The most common presentation is that of a relatively benign subacute illness, characterized by cough, dyspnea, and
REFERENCES (17)
- et al.
Cardiac dysrhythmia following pneumonectomy: clinical correlates and prognostic significance
Chest
(1987) - et al.
Digoxin and propranolol in the prophylaxis of supraventricular tachydysrhythmias after coronary artery bypass surgery
Ann Thorac Surg
(1981) - et al.
Verapamil prophylaxis for postoperative atrial dysrhythmias: a prospective, randomized, double-blind study using drug level monitoring
Ann Thorac Surg
(1987) - et al.
Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study
Am Heart J
(1991) - et al.
Pharmacokinetics of verapamil: experience with a sustained intravenous infusion regimen
Am J Cardiol
(1982) - et al.
Amiodarone pulmonary toxicity: recognition and pathogenesis. Part I
Chest
(1988) Clinical aspects of amiodarone pulmonary toxicity
Clin Chest Med
(1990)- et al.
Fatal postoperative amiodarone pulmonary toxicity
Am J Cardiol
(1988)